FDA Warns Against Bystolic For Heart Patients
Researchers at the U.S. Food and Drug Administration are urging the agency not to approve Forest Laboratories Inc.'s hypertension drug Bystolic for use with heart failure patients....To view the full article, register now.
Already a subscriber? Click here to view full article